Emergency Use of OCR-002 in Acute Liver Failure (ALF)

NO_LONGER_AVAILABLE

Conditions studied: Acute Liver Failure

In brief

This study provides emergency use of the unapproved study medication in ALF patients with acute liver failure who are not responding to standard of care.

Key facts

Study ID

NCT01634230

Run by

Ocera Therapeutics, Inc.

Last updated by the study team

2021-06-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• International Normalized Ratio (INR) ≥1.5 with encephalopathy in patient with no prior history of liver disease
• Venous ammonia level of ≥ 100 μmol/L

You may not qualify if…

• Patients who are pregnant

Where it is running

• University of Arkansas — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.